[Form 4] REVVITY, INC. Insider Trading Activity
Rhea-AI Filing Summary
Revvity, Inc. Senior Vice President, Administration, General Counsel and Secretary Joel S. Goldberg reported multiple equity transactions. On February 4, 2026, 869 common shares were withheld at $101.13 to cover taxes on vested restricted stock units, and he received 6,427 time-based restricted stock units plus a nonqualified stock option for 18,383 shares at an exercise price of $103.395, each scheduled to vest in three equal annual installments beginning on the first anniversary of grant.
On February 5, 2026, a previously granted stock option for 12,717 shares was exercised at $92.09 and the same number of common shares was sold in several transactions at weighted average prices between $98.98 and $103.03 under a Rule 10b5-1 trading plan adopted on February 6, 2025. After these transactions, Goldberg directly held 43,247 common shares, and 63,709 additional shares were held indirectly by the Goldberg Irrevocable 2021 Trust for his children, for which he disclaims beneficial ownership except for any pecuniary interest. The filing also corrects a prior Form 4 by clarifying that an earlier restricted stock unit grant vests in three equal annual installments starting one year after grant.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | NQ Stock Option (right to buy) | 12,717 | $0.00 | -- |
| Exercise | Common Stock | 12,717 | $92.09 | $1.17M |
| Sale | Common Stock | 6,424 | $99.47 | $639K |
| Sale | Common Stock | 3,544 | $100.50 | $356K |
| Sale | Common Stock | 2,217 | $101.33 | $225K |
| Sale | Common Stock | 532 | $102.52 | $55K |
| Grant/Award | NQ Stock Option (right to buy) | 18,383 | $0.00 | -- |
| Tax Withholding | Common Stock | 869 | $101.13 | $88K |
| Grant/Award | Common Stock | 6,427 | $0.00 | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- The vesting schedule for the restricted stock unit grant to the Reporting Person included in the Form 4 filed on February 6, 2025 was incorrectly reported due to administrative error. The restricted stock unit grant included in that Form 4 is scheduled to vest in three equal annual installments beginning on the first anniversary of the date of grant. These shares are being surrendered to satisfy a tax withholding obligation upon vesting of restricted stock units originally granted on February 4, 2025, as required by the Reporting Person's Restricted Stock Unit Agreement. Shares are time-based restricted stock units that are scheduled to vest in three equal annual installments beginning on the first anniversary of the date of grant. The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 6, 2025. The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $98.98 to $99.97. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $99.98 to $100.95. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $100.98 to $101.93. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $102.18 to $103.03. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. Securities held in an irrevocable trust for the sole benefit of the Reporting Person's children. The Reporting Person's spouse is the trustee of the trust. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest, if any, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. This option is scheduled to vest in three equal annual installments beginning on the first anniversary of the date of grant. This option became exercisable in three equal annual installments beginning on February 5, 2020, which was the first anniversary of the date on which the option was granted.
